Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 286-061-6 | CAS number: 85186-76-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
According to the results of the studies performed on differents substances which belong to LCAE category, a No Observed Adverse Effect Level can be derived for the registered substance, the 2-ethyl hexyl isostearate, at 1000 mg/kg bw/day for rats. No adverse effect or toxicity was observed on the studies, the substance was not classified for STOT-RE according to CLP regulation.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Read Across Category Endpoint Target Substance Record
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: according to the results of available studies
- Critical effects observed:
- no
- Conclusions:
- According to the results of the available studies for LCAE Category members, the NOAEL value was defined at 1000 mg/kg bw/day. According to the CLP criteria and the Category Members results, the registered substance was not classified for repeated dose toxicity.
- Executive summary:
According to the Regulation (EC) NO. 1907/2006, Annex XI, 1.5, A Read-Across Category for Long Chain Fatty Acid was performed in order to provide informations on the Isostearate Ethyl Hexyl.
This category was based on common and shared physico-chemical and structural properties as:
- common functional group,
- common precursors and the likehood of common impurities as well as common breakdown products via biological processes, which are chemically structurally similar, and
- constant pattern in the changing of the potency of the properties across the category.
The fatty acids linked with 2-ethylhexyl esters have a common metabolic fate in organisms as glycolytic and fatty acid pathways after first hydrolysis step which led in breakdown products. The common toxicokinetic properties and behavior are expected due to the constant pattern (ethylhexyl esters and the fatty acid chain). The toxicological profiles between the members of the category are expected to be the same.
Two key studies were available dor repeated dose oral toxicity, and were performed on Fatty acids, C16-18, 2-ethylhexyl esters and fatty acids C8 -C16, 2 -ethylhexyl esters. On the two 28 days repeated toxicity study, rats were dosed once daily. The NOAEL was defined at 1000 mg/kg bw/day due to absence of systemic effects in this two studies.
According to the results of the available studies for LCAE Category members, the NOAEL value was defined at 1000 mg/kg bw/day. According to the CLP criteria and the Category Members results, the registered substance was not classified for STOT-RE.
Reference
Table 1: Results from key studies on source chemicals of the category forRepeatedoral dose toxicity tests
ID# |
CAS |
Repeated dose toxicity |
Fatty acids, C8-16, 2- |
135800-37-2 |
Experimental Result : NOAEL : 1000 mg/kgbw/day |
Fatty acids, coco, 2-ethylhexyl esters |
92044-87-6 |
No data |
2-Ethylhexyl palmitate |
29806-73-3 |
No data |
Fatty acids, C16-18 and C18-unsatd., 2- |
85049-37-2 |
No data |
Fatty acids, C16-18, 2-ethylhexyl esters |
91031-48-0 |
Experimental result: NOAEL: 1000 mg/kgbw/day |
2-Ethylhexyloleate |
26399-02-0 |
No data |
2-Ethylhexylstearate |
22047-49-0 |
No data |
Similar toxicokinetic behavior and toxicity profile
All category members are subject to enzymatic hydrolysis by pancreatic lipases resulting in free acids and alcohol. Based on current literature, when absorbed from intestines and carried through blood stream, fatty acids are oxidized by beta-oxydation pathway in order to provide energy for cell and stored as glycerides esters in fat deposit. The alcohols are primarily metabolized in the liver.
Hence, it can be stated that the members of the category have the same toxicity due to the same metabolic pathways when absorbed in the organisms.
Based on the available key studies, the members of the category were considered as not irritating when applied on eye. Hence, the target substance was not classified for repeated oral toxicity according to CLP criteria.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Additional information
Justification and rationale of the category approach for the isostearate ethyl hexyl :
This category group covers 2-ethyl hexyl esters linked with fatty acid chains (C8 to C18) unsatured and satured. This category includes monoconstituent substances and UVCB substances varying fatty acid chain length. This category was made in order to provide sufficient information for physicochemical, ecotoxicological and toxicological caracterisation of the Fatty acids, C14-18 and C18-unsatd., branched and linear, 2-ethylhexyl esters (CAS No 85186-76-1)
The category group includes:
- 2-Ethyl hexyl stearate (CAS No 22047-49-0)
- Fatty acids, C8-16, 2-ethylhexyl esters (CAS No 135800-37-2)
- Fatty acids, C16-18 and C18-unsatd., 2-ethylhexyl esters (CAS No 85049-37-2)
- Fatty acids, coco, 2-ethylhexyl esters (CAS No 92044-87-6)
- Fatty acids, C16-18, 2-ethylhexyl esters (CAS No 91031-48-0)
- Fatty acids, C8-16, 2-ethylhexyl esters (CAS No 135800-37-2)
- 2-Ethylhexyl oleate (CAS No 26399-02-0)
Target substance for Category Approach : Fatty acids, C14-18 and C18-unsatd., branched and linear, 2-ethylhexyl esters (CAS No 85186-76-1)
In accordance with article 13 (1) of Regulation (EC) No. 1907.2006, “information on intrinsic properties of substances may be generated by means other than tests, provided that the conditions set out in Annex XI are met. In particular for human toxicity, environmental fate and ecotoxicity, information shall be generated whenever possible by means other than vertebrate animal tests which includes the use of information from structurally related substances (grouping or read across)”. Therefore, the available experimental data were collected and evaluated according to Annex XI requirements.
Summary of available studies
Fatty Acids, C8-16, 2-Ethylhexyl Esters CAS 135800-37-2
The oral toxicity after daily oral administration for 28 consecutive days of Fatty Acids, C8-16, 2-Ethylhexyl Esters (CAS# 135800-37-2) was tested according to OECD Guideline 407 and GLP (Fitzgerald, 1991). Groups of 5 male and female Sprague-Dawley rats received daily oral gavage doses of the test substance in corn oil at dose levels of 0, 100, 300 and 1000 mg/kg bw/d. Concurrent negative control animals received the vehicle alone. Based on clinical observations, neurological observations, examinations of various blood parameters (haematology and clinical chemistry), necropsy observations, organ weights, body weights, food consumption and histopathological findings, the 28d oral NOAEL for male and female rats was found to be 1000 mg/kg bw/d.
Fatty acids, C16-18, 2-ethylhexyl esters CAS 91031-48-0
The chemical was tested for systemic toxicity at repeated doses of 0, 100, 500 and 1000 mg/kg body weight. The compound was administered to Sprague-Dawley rats daily by gavage over a period of 28 days. All doses applied were tolerated without lethality. No symptoms were noted as compound-related effects. The total body weight gain was comparable to control in all male and female test groups. The haematological examinations showed no compound-related effects. The clinical chemistry showed no compound-related effects. The examination of the eyes by slit lamp microscope showed no compound-related effects. The absolute and relative organ weights showed no compound-related effects. The macroscopical examination of the organs displayed no compound-related effects. Some observations like hydrometra, hydronephrosis, discolouration of the thymus and one suspicion of hydrocephalus internus were considered to be spontaneous. The histological examination of the organs of all groups displayed no compound-related effects.
According to the results of the available studies, the NOAEL value was defined at 1000 mg/kg bw/day. According to the CLP criteria and the Category Members results from this two key studies, the registered substance was not classified for repeated dose toxicity.
Justification for classification or non-classification
According to the results of the studies performed on differents substances which belong to LCAE category, a No Observed Adverse Effect Level can be derived for the registered substance, the 2-ethyl hexyl isostearate, at 1000 mg/kg bw/day. No adverse effect or toxicity was observed on the studies, the substance was not classified for STOT-RE according to CLP regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.